Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNABW) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to 231.78%.

  • Ginkgo Bioworks Holdings' EBIT Margin fell 1697900.0% to 231.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 192.76%, marking a year-over-year increase of 982600.0%. This contributed to the annual value of 246.54% for FY2024, which is 972200.0% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' EBIT Margin stood at 231.78%, which was down 1697900.0% from 132.13% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' EBIT Margin ranged from a high of 34.37% in Q3 2021 and a low of 1134.55% during Q4 2021
  • Moreover, its 5-year median value for EBIT Margin was 236.29% (2024), whereas its average is 354.91%.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' EBIT Margin crashed by -9602100bps in 2021, and later skyrocketed by 8996600bps in 2022.
  • Ginkgo Bioworks Holdings' EBIT Margin (Quarter) stood at 1134.55% in 2021, then surged by 79bps to 234.89% in 2022, then plummeted by -118bps to 512.49% in 2023, then soared by 54bps to 236.29% in 2024, then increased by 2bps to 231.78% in 2025.
  • Its EBIT Margin stands at 231.78% for Q3 2025, versus 132.13% for Q2 2025 and 184.13% for Q1 2025.